The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pertussis Vaccination Market Research Report 2025
Synopsis
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
The global Pertussis Vaccination market was valued at US$ 5187.9 million in 2023 and is anticipated to reach US$ 6633.9 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pertussis Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pertussis Vaccination.
Report Scope
The Pertussis Vaccination market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pertussis Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pertussis Vaccination manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
Segment by Type
Acellular Vaccines
Whole-cell Vaccines
Segment by Application
12 Months Below
12 Months Above
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pertussis Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pertussis Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
The global Pertussis Vaccination market was valued at US$ 5187.9 million in 2023 and is anticipated to reach US$ 6633.9 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pertussis Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pertussis Vaccination.
Report Scope
The Pertussis Vaccination market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pertussis Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pertussis Vaccination manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
Segment by Type
Acellular Vaccines
Whole-cell Vaccines
Segment by Application
12 Months Below
12 Months Above
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pertussis Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pertussis Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pertussis Vaccination Market Overview
1.1 Product Overview and Scope of Pertussis Vaccination
1.2 Pertussis Vaccination Segment by Type
1.2.1 Global Pertussis Vaccination Market Value Comparison by Type (2024-2030)
1.2.2 Acellular Vaccines
1.2.3 Whole-cell Vaccines
1.3 Pertussis Vaccination Segment by Application
1.3.1 Global Pertussis Vaccination Market Value by Application: (2024-2030)
1.3.2 12 Months Below
1.3.3 12 Months Above
1.4 Global Pertussis Vaccination Market Size Estimates and Forecasts
1.4.1 Global Pertussis Vaccination Revenue 2019-2030
1.4.2 Global Pertussis Vaccination Sales 2019-2030
1.4.3 Global Pertussis Vaccination Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pertussis Vaccination Market Competition by Manufacturers
2.1 Global Pertussis Vaccination Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pertussis Vaccination Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pertussis Vaccination Average Price by Manufacturers (2019-2024)
2.4 Global Pertussis Vaccination Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pertussis Vaccination, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pertussis Vaccination, Product Type & Application
2.7 Pertussis Vaccination Market Competitive Situation and Trends
2.7.1 Pertussis Vaccination Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pertussis Vaccination Players Market Share by Revenue
2.7.3 Global Pertussis Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pertussis Vaccination Retrospective Market Scenario by Region
3.1 Global Pertussis Vaccination Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pertussis Vaccination Global Pertussis Vaccination Sales by Region: 2019-2030
3.2.1 Global Pertussis Vaccination Sales by Region: 2019-2024
3.2.2 Global Pertussis Vaccination Sales by Region: 2025-2030
3.3 Global Pertussis Vaccination Global Pertussis Vaccination Revenue by Region: 2019-2030
3.3.1 Global Pertussis Vaccination Revenue by Region: 2019-2024
3.3.2 Global Pertussis Vaccination Revenue by Region: 2025-2030
3.4 North America Pertussis Vaccination Market Facts & Figures by Country
3.4.1 North America Pertussis Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pertussis Vaccination Sales by Country (2019-2030)
3.4.3 North America Pertussis Vaccination Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pertussis Vaccination Market Facts & Figures by Country
3.5.1 Europe Pertussis Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pertussis Vaccination Sales by Country (2019-2030)
3.5.3 Europe Pertussis Vaccination Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pertussis Vaccination Market Facts & Figures by Country
3.6.1 Asia Pacific Pertussis Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pertussis Vaccination Sales by Country (2019-2030)
3.6.3 Asia Pacific Pertussis Vaccination Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pertussis Vaccination Market Facts & Figures by Country
3.7.1 Latin America Pertussis Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pertussis Vaccination Sales by Country (2019-2030)
3.7.3 Latin America Pertussis Vaccination Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pertussis Vaccination Market Facts & Figures by Country
3.8.1 Middle East and Africa Pertussis Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pertussis Vaccination Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pertussis Vaccination Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pertussis Vaccination Sales by Type (2019-2030)
4.1.1 Global Pertussis Vaccination Sales by Type (2019-2024)
4.1.2 Global Pertussis Vaccination Sales by Type (2025-2030)
4.1.3 Global Pertussis Vaccination Sales Market Share by Type (2019-2030)
4.2 Global Pertussis Vaccination Revenue by Type (2019-2030)
4.2.1 Global Pertussis Vaccination Revenue by Type (2019-2024)
4.2.2 Global Pertussis Vaccination Revenue by Type (2025-2030)
4.2.3 Global Pertussis Vaccination Revenue Market Share by Type (2019-2030)
4.3 Global Pertussis Vaccination Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pertussis Vaccination Sales by Application (2019-2030)
5.1.1 Global Pertussis Vaccination Sales by Application (2019-2024)
5.1.2 Global Pertussis Vaccination Sales by Application (2025-2030)
5.1.3 Global Pertussis Vaccination Sales Market Share by Application (2019-2030)
5.2 Global Pertussis Vaccination Revenue by Application (2019-2030)
5.2.1 Global Pertussis Vaccination Revenue by Application (2019-2024)
5.2.2 Global Pertussis Vaccination Revenue by Application (2025-2030)
5.2.3 Global Pertussis Vaccination Revenue Market Share by Application (2019-2030)
5.3 Global Pertussis Vaccination Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Corporation Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur Pertussis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Pasteur Pertussis Vaccination Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Pertussis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Pertussis Vaccination Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Mitsubishi Tanabe Pharma
6.3.1 Mitsubishi Tanabe Pharma Corporation Information
6.3.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccination Product Portfolio
6.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.4 KM Biologics
6.4.1 KM Biologics Corporation Information
6.4.2 KM Biologics Description and Business Overview
6.4.3 KM Biologics Pertussis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.4.4 KM Biologics Pertussis Vaccination Product Portfolio
6.4.5 KM Biologics Recent Developments/Updates
6.5 Wuhan Institute of Biological Products
6.5.1 Wuhan Institute of Biological Products Corporation Information
6.5.2 Wuhan Institute of Biological Products Description and Business Overview
6.5.3 Wuhan Institute of Biological Products Pertussis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Wuhan Institute of Biological Products Pertussis Vaccination Product Portfolio
6.5.5 Wuhan Institute of Biological Products Recent Developments/Updates
6.6 Walvax Biotechnology
6.6.1 Walvax Biotechnology Corporation Information
6.6.2 Walvax Biotechnology Description and Business Overview
6.6.3 Walvax Biotechnology Pertussis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Walvax Biotechnology Pertussis Vaccination Product Portfolio
6.6.5 Walvax Biotechnology Recent Developments/Updates
6.7 Chengdu Institute of Biological Products
6.6.1 Chengdu Institute of Biological Products Corporation Information
6.6.2 Chengdu Institute of Biological Products Description and Business Overview
6.6.3 Chengdu Institute of Biological Products Pertussis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chengdu Institute of Biological Products Pertussis Vaccination Product Portfolio
6.7.5 Chengdu Institute of Biological Products Recent Developments/Updates
6.8 Minhai Biotechnology
6.8.1 Minhai Biotechnology Corporation Information
6.8.2 Minhai Biotechnology Description and Business Overview
6.8.3 Minhai Biotechnology Pertussis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Minhai Biotechnology Pertussis Vaccination Product Portfolio
6.8.5 Minhai Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pertussis Vaccination Industry Chain Analysis
7.2 Pertussis Vaccination Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pertussis Vaccination Production Mode & Process
7.4 Pertussis Vaccination Sales and Marketing
7.4.1 Pertussis Vaccination Sales Channels
7.4.2 Pertussis Vaccination Distributors
7.5 Pertussis Vaccination Customers
8 Pertussis Vaccination Market Dynamics
8.1 Pertussis Vaccination Industry Trends
8.2 Pertussis Vaccination Market Drivers
8.3 Pertussis Vaccination Market Challenges
8.4 Pertussis Vaccination Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Pertussis Vaccination Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Pertussis Vaccination Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Pertussis Vaccination Market Competitive Situation by Manufacturers in 2023
Table 4. Global Pertussis Vaccination Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Pertussis Vaccination Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Pertussis Vaccination Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Pertussis Vaccination Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Pertussis Vaccination Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Pertussis Vaccination, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pertussis Vaccination, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pertussis Vaccination, Product Type & Application
Table 12. Global Key Manufacturers of Pertussis Vaccination, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pertussis Vaccination by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pertussis Vaccination as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pertussis Vaccination Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Pertussis Vaccination Sales by Region (2019-2024) & (K Units)
Table 18. Global Pertussis Vaccination Sales Market Share by Region (2019-2024)
Table 19. Global Pertussis Vaccination Sales by Region (2025-2030) & (K Units)
Table 20. Global Pertussis Vaccination Sales Market Share by Region (2025-2030)
Table 21. Global Pertussis Vaccination Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Pertussis Vaccination Revenue Market Share by Region (2019-2024)
Table 23. Global Pertussis Vaccination Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Pertussis Vaccination Revenue Market Share by Region (2025-2030)
Table 25. North America Pertussis Vaccination Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Pertussis Vaccination Sales by Country (2019-2024) & (K Units)
Table 27. North America Pertussis Vaccination Sales by Country (2025-2030) & (K Units)
Table 28. North America Pertussis Vaccination Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Pertussis Vaccination Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Pertussis Vaccination Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Pertussis Vaccination Sales by Country (2019-2024) & (K Units)
Table 32. Europe Pertussis Vaccination Sales by Country (2025-2030) & (K Units)
Table 33. Europe Pertussis Vaccination Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Pertussis Vaccination Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Pertussis Vaccination Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Pertussis Vaccination Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Pertussis Vaccination Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Pertussis Vaccination Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Pertussis Vaccination Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pertussis Vaccination Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Pertussis Vaccination Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Pertussis Vaccination Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Pertussis Vaccination Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pertussis Vaccination Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Pertussis Vaccination Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Pertussis Vaccination Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Pertussis Vaccination Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Pertussis Vaccination Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Pertussis Vaccination Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Pertussis Vaccination Sales (K Units) by Type (2019-2024)
Table 51. Global Pertussis Vaccination Sales (K Units) by Type (2025-2030)
Table 52. Global Pertussis Vaccination Sales Market Share by Type (2019-2024)
Table 53. Global Pertussis Vaccination Sales Market Share by Type (2025-2030)
Table 54. Global Pertussis Vaccination Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Pertussis Vaccination Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Pertussis Vaccination Revenue Market Share by Type (2019-2024)
Table 57. Global Pertussis Vaccination Revenue Market Share by Type (2025-2030)
Table 58. Global Pertussis Vaccination Price (US$/Unit) by Type (2019-2024)
Table 59. Global Pertussis Vaccination Price (US$/Unit) by Type (2025-2030)
Table 60. Global Pertussis Vaccination Sales (K Units) by Application (2019-2024)
Table 61. Global Pertussis Vaccination Sales (K Units) by Application (2025-2030)
Table 62. Global Pertussis Vaccination Sales Market Share by Application (2019-2024)
Table 63. Global Pertussis Vaccination Sales Market Share by Application (2025-2030)
Table 64. Global Pertussis Vaccination Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Pertussis Vaccination Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Pertussis Vaccination Revenue Market Share by Application (2019-2024)
Table 67. Global Pertussis Vaccination Revenue Market Share by Application (2025-2030)
Table 68. Global Pertussis Vaccination Price (US$/Unit) by Application (2019-2024)
Table 69. Global Pertussis Vaccination Price (US$/Unit) by Application (2025-2030)
Table 70. Sanofi Pasteur Corporation Information
Table 71. Sanofi Pasteur Description and Business Overview
Table 72. Sanofi Pasteur Pertussis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Sanofi Pasteur Pertussis Vaccination Product
Table 74. Sanofi Pasteur Recent Developments/Updates
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Pertussis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. GSK Pertussis Vaccination Product
Table 79. GSK Recent Developments/Updates
Table 80. Mitsubishi Tanabe Pharma Corporation Information
Table 81. Mitsubishi Tanabe Pharma Description and Business Overview
Table 82. Mitsubishi Tanabe Pharma Pertussis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Mitsubishi Tanabe Pharma Pertussis Vaccination Product
Table 84. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 85. KM Biologics Corporation Information
Table 86. KM Biologics Description and Business Overview
Table 87. KM Biologics Pertussis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. KM Biologics Pertussis Vaccination Product
Table 89. KM Biologics Recent Developments/Updates
Table 90. Wuhan Institute of Biological Products Corporation Information
Table 91. Wuhan Institute of Biological Products Description and Business Overview
Table 92. Wuhan Institute of Biological Products Pertussis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Wuhan Institute of Biological Products Pertussis Vaccination Product
Table 94. Wuhan Institute of Biological Products Recent Developments/Updates
Table 95. Walvax Biotechnology Corporation Information
Table 96. Walvax Biotechnology Description and Business Overview
Table 97. Walvax Biotechnology Pertussis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Walvax Biotechnology Pertussis Vaccination Product
Table 99. Walvax Biotechnology Recent Developments/Updates
Table 100. Chengdu Institute of Biological Products Corporation Information
Table 101. Chengdu Institute of Biological Products Description and Business Overview
Table 102. Chengdu Institute of Biological Products Pertussis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Chengdu Institute of Biological Products Pertussis Vaccination Product
Table 104. Chengdu Institute of Biological Products Recent Developments/Updates
Table 105. Minhai Biotechnology Corporation Information
Table 106. Minhai Biotechnology Description and Business Overview
Table 107. Minhai Biotechnology Pertussis Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Minhai Biotechnology Pertussis Vaccination Product
Table 109. Minhai Biotechnology Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Pertussis Vaccination Distributors List
Table 113. Pertussis Vaccination Customers List
Table 114. Pertussis Vaccination Market Trends
Table 115. Pertussis Vaccination Market Drivers
Table 116. Pertussis Vaccination Market Challenges
Table 117. Pertussis Vaccination Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pertussis Vaccination
Figure 2. Global Pertussis Vaccination Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pertussis Vaccination Market Share by Type in 2023 & 2030
Figure 4. Acellular Vaccines Product Picture
Figure 5. Whole-cell Vaccines Product Picture
Figure 6. Global Pertussis Vaccination Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Pertussis Vaccination Market Share by Application in 2023 & 2030
Figure 8. 12 Months Below
Figure 9. 12 Months Above
Figure 10. Global Pertussis Vaccination Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Pertussis Vaccination Market Size (2019-2030) & (US$ Million)
Figure 12. Global Pertussis Vaccination Sales (2019-2030) & (K Units)
Figure 13. Global Pertussis Vaccination Average Price (US$/Unit) & (2019-2030)
Figure 14. Pertussis Vaccination Report Years Considered
Figure 15. Pertussis Vaccination Sales Share by Manufacturers in 2023
Figure 16. Global Pertussis Vaccination Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Pertussis Vaccination Players: Market Share by Revenue in 2023
Figure 18. Pertussis Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Pertussis Vaccination Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Pertussis Vaccination Sales Market Share by Country (2019-2030)
Figure 21. North America Pertussis Vaccination Revenue Market Share by Country (2019-2030)
Figure 22. United States Pertussis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Pertussis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Pertussis Vaccination Sales Market Share by Country (2019-2030)
Figure 25. Europe Pertussis Vaccination Revenue Market Share by Country (2019-2030)
Figure 26. Germany Pertussis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Pertussis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Pertussis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Pertussis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Pertussis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Pertussis Vaccination Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Pertussis Vaccination Revenue Market Share by Region (2019-2030)
Figure 33. China Pertussis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Pertussis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Pertussis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Pertussis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Pertussis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Pertussis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Pertussis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Pertussis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Pertussis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Pertussis Vaccination Sales Market Share by Country (2019-2030)
Figure 43. Latin America Pertussis Vaccination Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Pertussis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Pertussis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Pertussis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Pertussis Vaccination Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Pertussis Vaccination Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Pertussis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Pertussis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Pertussis Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Pertussis Vaccination by Type (2019-2030)
Figure 53. Global Revenue Market Share of Pertussis Vaccination by Type (2019-2030)
Figure 54. Global Pertussis Vaccination Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Pertussis Vaccination by Application (2019-2030)
Figure 56. Global Revenue Market Share of Pertussis Vaccination by Application (2019-2030)
Figure 57. Global Pertussis Vaccination Price (US$/Unit) by Application (2019-2030)
Figure 58. Pertussis Vaccination Value Chain
Figure 59. Pertussis Vaccination Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
